Credit Suisse Ag Prothena Corp Public LTD CO Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
A detailed history of Credit Suisse Ag transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Credit Suisse Ag holds 60,202 shares of PRTA stock, worth $803,094. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,202
Previous 59,304
1.51%
Holding current value
$803,094
Previous $2.16 Million
30.81%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding PRTA
# of Institutions
198Shares Held
44.5MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$155 Million7.5% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$51.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$49.2 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$29.8 Million0.44% of portfolio
-
State Street Corp Boston, MA1.86MShares$24.8 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $626M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...